City of Hope 96144 Molecular Genetics Studies of Cancer Patients and Their Relatives
- Result Type
- clinical trial
The purpose of this study is to find out how genetics, biologics and behavior might contribute to
Status: Active, Recruiting
6results found for:
Locally Advanced or Metastatic (NRG GY012)
- Result Type
- clinical trial
Recurrent or Persistent Endometrial Cancer Comparing Olaparib, Cediranib, and Combinations of Cediranib/Olaparib, Olaparib/Durvalumab, Cedira/Durva, Ola/AZD5363
Status: Active, Recruiting
Metastatic (NRG GY018)
- Result Type
- clinical trial
Testing Addition of Immunotherapy Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer
Status: Active, Recruiting
Metastatic (Sutro STRO-002-GM1)
- Result Type
- clinical trial
Study of STRO-002, an Anti-Folate Receptor Alpha (FolRa) Antibody Drug Conjugate in Ovarian & Endometrial Cancers
Targeted Therapy (ASCO TAPUR)
- Result Type
- clinical trial
Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Status: Active, Recruiting
Targeted Therapy (Match EAY131)
- Result Type
- clinical trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, lymphoma, and myeloma
Status: Active, Recruiting